SENA RESEARCH, INC.

Biotech · Private

Selenium-derivatized nucleic acids (SeNA) and Se-building block reagents for X-ray crystallography structure determination

Grants
$1.1M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Selenium-derivatized New Reagents for Nucleic Acid X-ray Crystallography$307,889
Federal grantDepartment of Health and Human Services · Phase II · Selenium-derivatized New Reagents for Nucleic Acid X-ray Crystallography$750,567
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1992Primus Pharmaceuticals——
1993Acelerox, LLC——
1994ViceBio——
1995SENA RESEARCH, INC.——
1996Ionetix Corp / DE /—$32M
1997JYANT, INC.——
1998CERAMIDE THERAPEUTICS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Selenium Containing Nucleosides As Nutritional Supplementsapplication
  • Selenium Containing Nucleosides As Nutritional Supplementsapplication
  • Novel Compounds And Synthesis Of Tellurium-derivatized Oligonucleotides For Structural And Functional Studiesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.